Skip to main content

60 Degrees Pharmaceuticals, Inc. (SXTP)

NASDAQ: SXTP · IEX Real-Time Price · USD
0.620
-0.015 (-2.44%)
Nov 30, 2023, 4:00 PM EST - Market closed

SXTP Stock Forecast

Stock Price Forecast

According to 1 stock analyst, the 12-month stock price forecast for SXTP stock stock is $2.40, which predicts an increase of 287.10%. On average, analysts rate SXTP stock stock as a buy.

Analyst Consensus: Buy
Target Low Average Median High
Price $2.40 $2.40 $2.40 $2.40
Change +287.10% +287.10% +287.10% +287.10%
* Price targets were last updated on Oct 2, 2023.

Analyst Ratings

The average analyst rating for SXTP stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Oct '23Nov '23
Strong Buy 11
Buy 00
Hold 11
Sell 00
Strong Sell 00
Total 22

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Edward White
HC Wainwright & Co.
 HC Wainwright & Co.
Hold
Initiates
n/a
 Hold Initiates n/a n/a Oct 20, 2023
Lucas Ward
Ascendiant Capital
 Ascendiant Capital
Strong Buy
Initiates
$2
 Strong Buy Initiates $2 +287.10% Oct 2, 2023
Full Analyst Rating History

Financial Forecast

Revenue This Year
306.00K
from 78.84K
Increased by 288.13%
Revenue Next Year
816.00K
from 306.00K
Increased by 166.67%
EPS This Year
0.77
from 1.78
Decreased by -57.02%
EPS Next Year
-0.80
from 0.77
Year 20202021202220232024
Revenue
1.85M5.50M78.84K306.00K816.00K
Revenue Growth
-
197.98%
-98.57%
288.13%
166.67%
EPS
--1.780.77-0.80
EPS Growth
---
-57.02%
-
No. Analysts ---33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20232024
High 315,000 840,000
Avg 306,000 816,000
Low 294,000 784,000

Revenue Growth

Revenue Growth 20232024
High
299.5%
174.5%
Avg
288.1%
166.7%
Low
272.9%
156.2%

EPS Forecast

EPS 20232024
High 0.79 -0.82
Avg 0.77 -0.80
Low 0.74 -0.76

EPS Growth

EPS Growth 20232024
High
-55.8%
-
Avg
-57.0%
-
Low
-58.7%
-
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.